Integral Diagnostics Ltd

Integral Diagnostics Ltd is a medical imaging service provider operating throughout Australia and New Zealand, delivering diagnostic imaging solutions for healthcare practitioners and their patients. Integral Diagnostics Ltd specializes in advanced medical imaging services, with headquarters located in Melbourne, Australia. The company was formed through a merger and completed its IPO in October 2015, raising AUD 133. 7 mn.

Ian Kadish leads the company as CEO. Integral Diagnostics has successfully executed 3 deals, with the most recent deal dated August 26, 2016, when Advent Partners sold its remaining shares in the company. Integral Diagnostics (IDX) provides a broad array of medical imaging services, including MRI, CT scans, X-rays, and ultrasound. Their offerings support healthcare providers in efficient diagnosis and patient management, leveraging a model that integrates experienced radiologists to ensure high-quality service.

IDX serves various geographical markets, focusing on urban and regional areas such as Queensland, Victoria, Western Australia, Northern New South Wales, and Auckland. In the most recent fiscal year of 2023, Integral Diagnostics recorded a revenue of AUD 296,781,333. 80 and an EBITDA of AUD 61,988,071. 50.

The company's revenue model primarily derives from fee-for-service agreements with healthcare practitioners, charging for imaging procedures and enhancing service accessibility through partnerships. Integral Diagnostics intends to utilize the AUD 133. 7 mn raised during its IPO in 2015 to enhance its service capabilities and expand into new geographic regions. The company aims to introduce new imaging technologies and expand its footprint in urban areas across Australia and New Zealand, thereby increasing its market presence.

Specific plans for product launches and geographic expansion details will be disclosed as they materialize.